0001140361-24-033638.txt : 20240719
0001140361-24-033638.hdr.sgml : 20240719
20240719171835
ACCESSION NUMBER: 0001140361-24-033638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240717
FILED AS OF DATE: 20240719
DATE AS OF CHANGE: 20240719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Piccinini Laura
CENTRAL INDEX KEY: 0001875140
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 241128537
MAIL ADDRESS:
STREET 1: C/O ANGIODYNAMICS INC.
STREET 2: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4
1
form4.xml
FORM 4
X0508
4
2024-07-17
0001275187
ANGIODYNAMICS INC
ANGO
0001875140
Piccinini Laura
14 PLAZA DRIVE
LATHAM
NY
12110
true
SVP International
false
Common Stock
2024-07-17
4
A
0
21971
0
A
41064
D
Performance Right
2024-07-17
4
A
0
30428
0
A
Common Stock
30428
30428
D
Non-Qualified Stock Option (right to buy)
7.4
2024-07-17
4
A
0
29863
0
A
2025-07-17
2034-07-17
Common Stock
29863
29863
D
The acquisition of 21,971 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 21,971 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 17, 2025, such that 25% of the restricted stock units will vest on each of July 17, 2025, 2026, 2027 and 2028.
Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.
These stock options vest in four equal annual installments beginning on July 17, 2025, such that 25% of the options will vest on each of July 17, 2025, 2026, 2027 and 2028.
/s/ Stephen A. Trowbridge, Attorney in Fact
2024-07-19